Skip to content
The Nexus
DossierENTITY

Multicomponent blood-based biomarker test

Coverage of Multicomponent blood-based biomarker test in the Nexus archive.

Earliest in view: Jun 22 · 21:00 UTCMost recent: Jun 22 · 21:00 UTC
Co-mentioned in this coverage
prostate-specific antigentopic1plasma protein biomarkerstopic1polygenic risk scoretopic1clinical variablestopic1MedPage Todayorganization1
Recent coverage
  • HEALTHJun 22 · 21:00 UTCMEDPAGE TODAY
    Multicomponent Test Tops PSA for Clinically Significant Prostate Cancers

    A multicomponent blood-based biomarker test combining prostate-specific antigen (PSA), plasma protein biomarkers, a polygenic risk score, and clinical variables outperforms PSA alone in identifying clinically significant prostate cancers. The test integrates multiple factors to improve detection accuracy beyond traditional PSA screening.